Neurogene (NGNE) Operating Leases (2019 - 2025)
Historic Operating Leases for Neurogene (NGNE) over the last 5 years, with Q3 2025 value amounting to $7.1 million.
- Neurogene's Operating Leases fell 4551.67% to $7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 million, marking a year-over-year decrease of 4551.67%. This contributed to the annual value of $9.4 million for FY2024, which is 3672.7% down from last year.
- Neurogene's Operating Leases amounted to $7.1 million in Q3 2025, which was down 4551.67% from $7.8 million recorded in Q2 2025.
- Over the past 5 years, Neurogene's Operating Leases peaked at $14.9 million during Q4 2023, and registered a low of $7.1 million during Q3 2025.
- Moreover, its 3-year median value for Operating Leases was $9.5 million (2023), whereas its average is $10.7 million.
- As far as peak fluctuations go, Neurogene's Operating Leases soared by 4398.39% in 2024, and later tumbled by 4551.67% in 2025.
- Over the past 3 years, Neurogene's Operating Leases (Quarter) stood at $14.9 million in 2023, then crashed by 36.73% to $9.4 million in 2024, then decreased by 24.52% to $7.1 million in 2025.
- Its Operating Leases stands at $7.1 million for Q3 2025, versus $7.8 million for Q2 2025 and $8.6 million for Q1 2025.